Risk factors for mortality in end-stage kidney disease patients under online-hemodiafiltration: three-year follow-up study

References

• Bayoumi M, Al Harbi A, Al Suwaida A, et al. (2013). Predictors of quality of life in hemodialysis patients. Saudi J Kidney Dis Transpl 24:254–9.
   PubMedGoogle Scholar
• Canaud B, Bragg-Gresham JL, Marshall MR, et al. (2006). Mortality risk for patients receiving hemodiafiltration versus hemodialysis: European results from the DOPPS. Kidney Int 69:2087–93.
   PubMed Web of Science ®Google Scholar
• Collins AJ. (2003). Cardiovascular mortality in end-stage renal disease. Am J Med Sci 325:163–7.
   PubMed Web of Science ®Google Scholar
• Costa E, Pereira BJ, Rocha-Pereira P, et al. (2008). Role of prohepcidin, inflammatory markers and iron status in resistance to rhEPO therapy in hemodialysis patients. Am J Nephrol 28:677–83.
   PubMed Web of Science ®Google Scholar
• do Sameiro-Faria M, Ribeiro S, Costa E, et al. (2013). Risk factors for mortality in hemodialysis patients: two-year follow-up study. Dis Markers 35:791–8.
   PubMed Web of Science ®Google Scholar
• Ferreira PL, Anes EJ. (2010). Medição da qualidade de vida de insuficientes renais crónicos: criação da versão portuguesa do KDQOL-SF. Rev Port Sau Pub 28:31–9.
   Google Scholar
• Ferreira PL, Ferreira LN, Perereira LN. (2012). Medidas sumário física e mental do estado de saúde para a populacão portuguesa. Rev Port Sau Pub 30:163–71.
   Google Scholar
• Foley RN, Parfrey PS, Sarnak MJ. (1998). Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32:S112–19.
   PubMed Web of Science ®Google Scholar
• Garrido P, Ribeiro S, Fernandes J, et al. (2015). Resistance to recombinant human erythropoietin therapy in a rat model of chronic kidney disease associated anemia. Int J Mol Sci 17:pii:E28.
   PubMed Web of Science ®Google Scholar
• Hays RD, Kallich JD, Mapes DL, et al. (1994). Development of the kidney disease quality of life (KDQOL) instrument. Qual Life Res 3:329–38.
   PubMed Web of Science ®Google Scholar
• Held PJ, Brunner F, Odaka M, et al. (1990). Five-year survival for end-stage renal disease patients in the United States, Europe, and Japan, 1982 to 1987. Am J Kidney Dis 15:451–7.
   PubMed Web of Science ®Google Scholar
• Jacober ML, Mamoni RL, Lima CS, et al. (2007). Anaemia in patients with cancer: role of inflammatory activity on iron metabolism and severity of anaemia. Med Oncol 24:323–9.
   PubMed Web of Science ®Google Scholar
• Jager KJ, Lindholm B, Goldsmith D, et al. (2011). Cardiovascular and non-cardiovascular mortality in dialysis patients: where is the link? Kidney Int Suppl 1:21–3.
   Web of Science ®Google Scholar
• Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD. (2003). Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 63:793–808.
   PubMed Web of Science ®Google Scholar
• Kalantar-Zadeh K, Kilpatrick RD, Kuwae N, et al. (2005). Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction. Nephrol Dial Transplant 20:1880–8.
   PubMed Web of Science ®Google Scholar
• Kendrick J, Chonchol MB. (2008). Nontraditional risk factors for cardiovascular disease in patients with chronic kidney disease. Nat Clin Pract Nephrol 4:672–81.
   PubMedGoogle Scholar
• Knight EL, Ofsthun N, Teng M, et al. (2003). The association between mental health, physical function, and hemodialysis mortality. Kidney Int 63:1843–51.
   PubMed Web of Science ®Google Scholar
• Kouidi E. (2004). Health-related quality of life in end-stage renal disease patients: the effects of renal rehabilitation. Clin Nephrol 61:S60–71.
   PubMedGoogle Scholar
• Lacson E. Jr, Ikizler TA, Lazarus JM, et al. (2007). Potential impact of nutritional intervention on end-stage renal disease hospitalization, death, and treatment costs. J Ren Nutr 17:363–71.
   PubMed Web of Science ®Google Scholar
• Lowrie EG, Lew NL. (1990). Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 15:458–82.
   PubMed Web of Science ®Google Scholar
• Lowrie EG, Curtin RB, LePain N, Schatell D. (2003). Medical outcomes study short form-36: a consistent and powerful predictor of morbidity and mortality in dialysis patients. Am J Kidney Dis 41:1286–92.
   PubMed Web of Science ®Google Scholar
• Mapes DL, Lopes AA, Satayathum S, et al. (2003). Health-related quality of life as a predictor of mortality and hospitalization: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int 64:339–49.
   PubMed Web of Science ®Google Scholar
• Mapes DL, Bragg-Gresham JL, Bommer J, et al. (2004). Health-related quality of life in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 44:54–60.
   PubMedGoogle Scholar
• Mazairac AH, de Wit GA, Grooteman MP, et al. (2012). Clinical performance targets and quality of life in hemodialysis patients. Blood Purif 33:73–9.
   PubMed Web of Science ®Google Scholar
• Mazairac AH, de Wit GA, Grooteman MP, et al. (2013). Effect of hemodiafiltration on quality of life over time. Clin J Am Soc Nephrol 8:82–9.
   PubMed Web of Science ®Google Scholar
• Moura A, Madureira J, Alija P, et al. (2015). Predictors of health-related quality of life perceived by end-stage renal disease patients under online hemodiafiltration. Qual Life Res 24:1327–35.
   PubMed Web of Science ®Google Scholar
• Owen WF. Jr, Lew NL, Liu Y, et al. (1993). The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 329:1001–6.
   PubMed Web of Science ®Google Scholar
• Rebollo P, Ortega F, Baltar JM, et al. (1998). Health-related quality of life (HRQOL) in end stage renal disease (ESRD) patients over 65 years. Geriatr Nephrol Urol 8:85–94.
   PubMedGoogle Scholar
• Ribeiro S, Belo L, Reis F, Santos-Silva A. (2016). Iron therapy in chronic kidney disease: recent changes, benefits and risks. Blood Rev 30:65–72.
   PubMed Web of Science ®Google Scholar
• Sarnak MJ, Levey AS, Schoolwerth AC, et al. (2003). Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108:2154–69.
   PubMed Web of Science ®Google Scholar
• Stenvinkel P, Carrero JJ, Axelsson J, et al. (2008). Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? Clin J Am Soc Nephrol 3:505–21.
   PubMed Web of Science ®Google Scholar
• Tsai YC, Hung CC, Hwang SJ, et al. (2010). Quality of life predicts risks of end-stage renal disease and mortality in patients with chronic kidney disease. Nephrol Dial Transplant 25:1621–6.
   PubMed Web of Science ®Google Scholar
• Vollmer WM, Wahl PW, Blagg CR. (1983). Survival with dialysis and transplantation in patients with end-stage renal disease. N Engl J Med 308:1553–8.
   PubMed Web of Science ®Google Scholar
• Zimmermann J, Herrlinger S, Pruy A, et al. (1999). Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 55:648–58.
   PubMed Web of Science ®Google Scholar